New guidelines governing the sale and display of codeine-containing drugs such as Solpadeine and Nurofen Plus come into effect today.
Pharmacists will also have to ensure customers know how to use such medicines properly, according to the Pharmaceutical Society of Ireland (PSI), which regulates the profession.
Codeine medicines such as painkillers and cough bottles must only be supplied under the personal supervision of a pharmacist, who must advise customers that they only be used when considered necessary and for the shortest time possible, the new rules state.
Patients should be advised of the importance of sticking to the recommended dose and duration of use, and of risks of developing tolerance and dependence.
They will also be warned about the potential dangers of combination products – painkillers containing codeine and another drug such as paracetamol or ibuprofen – and advised about potential side-effects such as drowsiness.
Where patients are misusing codeine, pharmacists will have to help them seek medical help, the guidelines state. All advertising of codeine products, including window displays and leaflets, is prohibited.
The PSI said it will use inspectors and “mystery customers” to ensure compliance.